Apollo Device for Metastatic Breast Cancer (MBC)
Clinical trial NCT04983342 · COMPLETED
Trial details
- NCT number
- NCT04983342
- Sponsor
- Margaret Quinn Rosenzweig
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-08-09
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.